Lower Risk Mds Or Mds Mpn clinical trials

Explore recruiting lower risk mds or mds mpn clinical trials.

Also recruiting in Europe

Lower Risk Mds Or Mds Mpn trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II, Single-Arm, Open-Label Study to Assess the Efficacy and Safety of Canakinumab for the Treatment of Anemia in Patients with IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes or MDS/MPN CANFIRE Trial

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Lower Risk Mds Or Mds Mpn trials by city

Lower Risk Mds Or Mds Mpn in Toronto Lower Risk Mds Or Mds Mpn in Vancouver Lower Risk Mds Or Mds Mpn in Montreal Lower Risk Mds Or Mds Mpn in Calgary Lower Risk Mds Or Mds Mpn in Edmonton Lower Risk Mds Or Mds Mpn in Ottawa Lower Risk Mds Or Mds Mpn in Winnipeg Lower Risk Mds Or Mds Mpn in Quebec City Lower Risk Mds Or Mds Mpn in Hamilton Lower Risk Mds Or Mds Mpn in Kitchener Lower Risk Mds Or Mds Mpn in London Lower Risk Mds Or Mds Mpn in Halifax Lower Risk Mds Or Mds Mpn in New York Lower Risk Mds Or Mds Mpn in Los Angeles Lower Risk Mds Or Mds Mpn in Chicago Lower Risk Mds Or Mds Mpn in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease